When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OMER - Omeros' OMS721 an Orphan Drug in U.S. for HSCT-associated clotting disorder; shares ahead 9%
Omeros Corporation
The FDA grants Orphan Drug status for Omeros' (OMER+8.9%) lead candidate OMS721 for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), a severe complication of HSCT characterized by blood clotting in the smallest blood vessels in the body.
More news on: Omeros Corporation, Healthcare stocks news, Stocks on the move,